Member Info for RayPointer

Try chopping 20% off a penny at the checkout

"All you do is talk talk talk what a boring stock."

Well yes it is boring laying the foundations. All that concrete mixing and nothing to show for it above ground.

Nice one Ruck

It also gives her the freedom to develop the science the way she wants.
There is no corporate executive telling her what areas to concentrate on.

".this is something I do not get with some making an issue of Lindy keeping her Notts position."

Yes, I agree with this. It gives Lindy another set of resources on the cheap.
And then and there is a 3rd set of resources at other universities.

When you see Lindy in full flow on one of her talks, do you see a jaded overworked scientist?
Well I don't, I see someone on a mission who knows exactly how to direct her research.
That web of acedemic contacts comes in useful too.

Yes, it will be interesting to see if that transaction is allowed to go through.

But regardless, it does highlight that Cross border payments is a hot area with the Chinese now joining in.

All bodes well for ESG.

Did you notice on that Ichor Job advert

"Must be able to lift up to 50 pounds on occasion"

Are they planning a device to treat elephants?

On a more serious note, perhaps one of the problems highlighted by the FDA was the lack of a procedure to quickly sort out problems with the device when employed in clinical trials, hence this job.

Do you have a link for that crumbs?
Thanks

I actually think that the next we will hear about the SCIB1 trial is when it has been approved and recruitment has started.
The pre-clinical period has its ups and downs and that is exactly why radio silence is observed during this period.
Would you want an RNS for each up and down?
We know, for instance, that Scancell do not RNS an IND submission.

I don't think Scancell can openly discuss what the issues are with the FDA.
These are surely confidential matters between Scancell, Ichor and the FDA.

Perhaps there are 5.
I've just received my Scancell ramping badge through the post. My first assigned task is to escort rich old widows across the road and strike up a conversation about Scancell.
First results have not been good. I keep getting accused of being a Jehovah's Witness and have got the bruises to prove it.
What do these old ladies keep in their handbags?

Perhaps the FDA project manager is waiting for a job offer from Pfizer

No doubt, but surely the first thing that the FDA should look at is the trial(s) where the new device version has been used.
Perhaps they are doing just that and looking at the trial that Wild has highlighted.

Yes, it is really puzzling what the FDA's questions are.
Is it perhaps something to do specifically with Melanoma i.e. a type of skin cancer?

Is when an inan argument is brewing.
I always switch off the tele when one is imminent.

LOL

Ruck

Initially for my own use.
When it goes live (still at least 6 months away) I am thinking of running on the following broker platform

https://www.darwinex.com/

This allows people to automatically replicate my trades and I get a percentage of all profits.
But my long term aim is to sell the software.
Great application leads to great trades leads to great deals. Sounds familiar LOL

My background is in programming but more importantly also in analysis.
It is very different to algorithmic routines that your son was successful with.
But the great thing is that I find it a challenge and just enjoy doing it.
Whether or not it becomes a success only time will tell.

Yes, I have already learnt not take any notice of so-called wonder trading systems.
There are many of these all out to take your money.

I am finding that there are a lot of trading situations.
I am building up a library or routines that I can use in each of these trading situations.

For example, when price reaches the high of yesterday is a potential sell trade. So I use the routines to tell me if today is going to repeat yesterday's price action. But it's all based on where the major players are trading.
They control the forex market (at least in the short term)

Anyway, I love doing it :)

Nom

Yes, as a language it is old but it has stood the test of time and is supported by many forex brokers and is still actively supported by the company that created it.

What I also like about it is that it is designed to be able to test without an internet connection.

What is important is not so much the code but the ideas. I tend to spend much more time on analysis as opposed to coding.

It often doesn't matter if the news is good or bad. What matters is where the big trades are.